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Background: Characteristics of non-steroidal anti-inflammatory drug (NSAID)-hypersensitivity
(NH) associated with underlying/accompanying diseases has not been studied in Turkey. In
addition, the factors associated with asthma in NH patients are not well known. The present
study aimed to investigate the relationship between NH and chronic urticaria, rhinitis/rhinosi-
nusitis, and asthma in an effort to identify NH phenotypes. The study’s secondary aim was to
identify the factors associated with asthma in NH patients and the NSAID reaction pattern in
asthmatics.
Methods: Data for 1137 NH patients in our hospital’s allergy clinic database were retrospec-
tively analyzed. Patients were divided into 5 groups based on their accompanying diseases
(chronic urticaria, asthma, rhinitis/rhinosinusitis). Asthmatic patients were compared to
non-asthmatic patients to identify the factors associated with asthma.
Results: Reaction patterns and patient characteristics in each group differed from those in the
reference group (NH only group). Asthma in patients with NH was associated with female
gender, sinonasal polyposis/polyp surgery, rhinitis/rhinosinusitis, NSAID-induced rhinitis/
asthma or a blended reaction pattern, immediate reaction following NSAID intake, self-
reported history of food allergy, and family history of asthma; the odds ratios and 95% CIs
were 1.35 (1.02e1.78), 13.52 (8.74e20.9)/10.94 (6.73e17.77), 12.06 (9e16.17), 15.28
(10.45e22.36)/2.43 (1.70e3.45), 1.76 (1.31e2.35), 1.49 (1.04e2.14), and 3.1 (2.35e4.08),
respectively. The characteristics of the asthmatic patients that had urticaria/angioedema-
type reactions to NSAID intake (pseudo Samter’s syndrome) differed from those in the asth-
matics with rhinitis/asthma-type reactions.2 305 1721; fax: þ90 312 305 3096.
o.co.uk (E. Celebioglu).
3 Elsevier Ltd. All rights reserved.
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968 G. Karakaya et al.Conclusions: Chronic urticaria, rhinitis, and asthma commonly accompany NH. NSAID response
patterns in NH patients may help differentiate groups of patients. The present study identified
factors associated with asthma in NH patients and observed that there seems to be different
phenotypes of Samter’s syndrome, for which a new classification scheme was proposed.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) account for
21%e25% of adverse drug events, and are the second most
common cause of drug-induced hypersensitivity re-
actions.1,2 A recent EAACI/ENDA group review published
data on the pathomechanisms and clinical spectrum of hy-
persensitivity reactions caused by NSAIDs.1 Depending on
the diagnostic methods used and study design, NSAID-
hypersensitivity (NH) in adult asthmatic patients, patients
with bronchial asthma and nasal polyps, and patients with
chronic urticaria can be as high as 21%, 25.6%, and 35%,
respectively; however, despite these high prevalences there
is lack of knowledge of the predictors of the clinical course
of NH, which could be of critical importance to clinicians.3e5
Aspirin, one of the most commonly consumed NSAIDs,
can induce wheals/angioedema in patients with chronic
urticaria via inhibition of COX-1.6 Such eicosanoid alter-
ations in patients with chronic idiopathic urticaria and
aspirin sensitivity are similar to those observed in aspirin-
exacerbated respiratory disease (AERD).7 Although the
pathomechanisms of aspirin-induced urticaria/angioedema
and AERD appear similar, there should be some differences,
or the 2 are different phenotypes of the same disease.
The presence of asthma and aspirin-induced asthmatic
symptom exacerbation is commonly referred as Samter’s
syndrome, aspirin-induced asthma, or AERD.8,9 There is also a
sub-group of patients with asthma and NH that experience
urticaria/angioedema-type reactions instead of broncho-
spasm in response to NSAIDs. The proportion of this sub-group
among asthmatics with NH is unknown; these patients may
constitute a different spectrum of Samter’s syndrome.
Characterizing NH can help improve clinician’s ability to
determine a prognosis and disease course. Some patients
can go into remission when the underlying disease subsides,
whereas asthma and/or rhinitis and/or chronic urticaria
can occur during the course of NH. As such, the present
study aimed to investigate the relation between NH and
chronic urticaria, rhinitis/rhinosinusitis, and asthma, and to
define NH phenotypes. The study’s secondary aim was to
identify the factors associated with asthma in NH patients
and the NSAID reaction pattern of asthmatics.
Materials and methods
Data collection
Data for 1137 patients diagnosed with NH-with or without
concurrent asthma, rhinitis/rhinosinusitis, and chronic
urticaria-that presented to Hacettepe University, School of
Medicine, Adult Allergy Clinic, Ankara, Turkey, between
January 1991 and December 2010 were retrospectivelyreviewed using the allergy clinic database. Data in the data-
basewerecollectedprospectively. Patientage, gender,NSAID
reaction patterns, accompanying diseases (rhinitis/rhinosi-
nusitis, asthma, chronic urticaria, and metal allergy), family
history of asthma/rhinitis/rhinosinusitis/NH, self-reported
NSAID reaction patterns, age of onset of NH/asthma/
rhinitis, and diagnostic work-up findings were recorded in the
allergy clinic database. Asthmaand rhinitiswerediagnosedby
allergy specialists at the study center based on international
and national asthma/rhinitis guidelines (GINA, ARIA and na-
tional guidelines), and the diagnosis and surgical treatment of
nasal polyps was made by otorhinolaryngologists at the same
center. Chronic urticaria was defined as spontaneous wheals
and/or angioedema >6weeks in duration.10Patients
A reliable clinical history of 2 events with the same NSAID
or 2 events with unrelated NSAIDs, or in case of an un-
reliable history, a positive oral challenge with the tested
NSAID were required for the diagnosis of NH. Patients with
delayed-type (reaction after 24 h of NSAID intake) skin or
systemic reactions to NSAIDs were not recorded into the
database. Single-blind oral drug provocation tests were
performed to confirm the diagnosis of NH (in cases with an
unreliable history) and/or to identify alternative analgesics
(in cases of a reliable history) following presentation to the
allergy clinic.1 As this is a data review study, all patients
diagnosed as NH between January 1991 and December 2010
were included in the analysis. All patients met the indica-
tion criteria for drug provocation testing described by the
European Network for Drug Allergy and European Network
on Hypersensitivity to Aspirin and Non-steroidal Anti-In-
flammatory Drugs.1,11 Written informed consent was ob-
tained from each patient before each provocation test and
the study protocol was approved by the Hacettepe Uni-
versity Ethics Committee (HEK 12/188-38).
While identifying safe alternative analgesics for patients
that did not reside in Ankara, in order to minimize cost and
manpower expenditures some patients were tested via the
Hacettepe method (triple test) starting in September
2002.12,13 Patients that were tolerant to a limited number
of alternative analgesics (e.g. only paracetamol) were
tested with codeine.14
Patients were divided into the following 5 groups: NH-N:
NH with no underlying disease (reference group); NH-A: NH
with asthma; NH-U: NH with chronic urticaria; NH-R: NH
with rhinitis; NH-O: NH and any combination of rhinitis,
asthma, and chronic urticaria.
Based on each patient’s history, NSAID reaction
patterns were classified as follows: anaphylaxis, urticaria/
angioedema, rhinitis/asthma, and blended reactions
NSAID hypersensitivity and asthma 969(any combination of the listed patterns other than
anaphylaxis).15,16 Asthmatic patients were compared to
non-asthmatic patients in order to identify factors associ-
ated with asthma.
Pseudo Samter’s syndrome was considered NSAID-
induced urticaria/angioedema in an asthmatic patient,
and Samter’s syndrome was considered NSAID-induced
anaphylaxis, rhinitis/asthma, or blended reactions in an
asthmatic patient.
Statistics
Statistical analysis was performed using SPSS v.18.0 for
Windows. Categorical variables were expressed as a fre-
quency, versus mean  SD for continuous variables. Chi-
square analysis was used to test differences between
nominal variables and the t-test was used for interval var-
iables between two groups. The level of statistical signifi-
cance was set at p < 0.05. Variables were analyzed using
logistic regression with adjustment for age and gender to
identify independent associations with asthma.
Results
Patients
The study included 1137 patients with data entered in the
database. In all, 416 (36.6%) of the patients were in the NH-Table 1 Characteristics of the patient groups and comparison w
Total n (%) NH-Na
416 (37)
NH-Aa
64 (6)
P1 NH
14
Age at registration in
database, mean  SD
39.6  13 43  14 0.05 40
Female/male % 70/30 80/20 0.12 71
Self-reported reaction
typeb n (%)
 Anaphylaxis: 128 (11) 53 (13) 7 (11) 0.69 16
 Rhinitis/asthma: 229 (20) 9 (2) 23 (36) <0.001 2 (
 Urticaria/angioedema:
631(56)
312 (75) 26 (41) <0.001 11
 Blended: 148 (13) 42 (10) 8 (12) 0.56 6 (
Time to onset of reaction
n (%)
 <1 h: 789 (72) 265 (66) 46 (74) 0.21 90
 1e6 h: 276 (25) 116 (29) 16 (26) 0.6 43
 6e24 h: 28 (3) 19 (5) 0 NA 3 (
Antibiotic hypersensitivity:
198 (17.4)
93 (22) 11 (17) 0.35 21
Food allergy: 141 (12.4) 38 (9) 10 (16) 0.11 22
Metal allergy: 166 (14.6) 41 (10) 10 (16) 0.16 41
Comparisons were made via the chi-square test for categorical variab
P1: Comparison between the NH-A and NH-N groups.
p2: Comparison between the NH-U and NH-N groups.
p3: Comparison between the NH-R and NH-N groups; p4: Comparison
NA: Not applicable.
The p values <0.05 are indicated in bold.
a NHeN: NH with no underlying disease (reference group); NH-A: N
rhinitis; NHeO: NH and any combination of rhinitis, asthma, and chro
b A patient that did not report a reaction pattern.N group (reference group), 64 (5.6%) were in the NH-A
group, 142 (12.5%) were in the NH-U group, 134 (11.8%)
were in the NH-R group, and 381 (33.5%) were in the NH-O
group (Table 1). Mean age of the study population (72.6%
female and 27.4% male) was 39.99  12.4 years (range:
16e86 years). Mean age of onset of rhinitis, asthma, and NH
were 28.1  11.9 years, 32.4  12.4 years, and 34.2  12.8
years, respectively. Rhinitis/rhinosinusitis/nasal polyposis
were common among the asthma patients (68%) (Fig. 1).Groups characteristics and comparison with the
reference group (NH-N)
The most common reaction pattern to NSAIDs was urticaria/
angioedema (56%). The predominant reaction pattern was
urticaria/angioedema in the NH-N and NH-U groups (75%
and 83%, respectively), versus NSAID-induced rhinitis/
asthma in the NH-O group (45%). Based on patient histories,
reactions to NSAIDs occurred <1 h after intake in 72% of the
patients. The characteristics of the NH-O group differed
from those in the NH-N (reference) group (Table 1).Drug provocation tests
In order to prove NH and/or to identify alternative anal-
gesics 545 oral challenges were performed with meloxicam,
431 with paracetamol, 409 with nimesulide, 321 withith the reference group (NH-N groupa).
-Ua
2 (12)
P2 NH-Ra
134 (12)
P3 NH-Oa
381 (33)
P4
 12 0.62 38  11 0.2 40.5  12 0.3
/29 0.79 72/28 0.6 75/25 0.1
(11) 0.65 17 (13) 0.1 35 (9) 0.11
2) 0.58 25 (19) <0.001 170 (45) <0.001
8 (83) 0.04 73 (55) <0.001 102 (27) <0.001
4) 0.03 18 (13) 0.27 74 (19) <0.001
(66) 1 99 (77) 0.02 289 (79) <0.001
(32) 0.56 26 (20) 0.05 75 (20) 0.006
2.2) 0.2 3 (2) 0.24 3 (1) 0.001
(15) 0.05 16 (12) 0.009 57 (15) 0.008
(15) 0.03 12 (9) 0.9 59 (15) 0.006
(29) <0.001 13 (10) 0.96 61 (16) 0.009
les and the t test for continuous variables, where appropriate.
between the NH-O and NH-N groups.
H with asthma; NH-U: NH with chronic urticaria; NH-R: NH with
nic urticaria.
Figure 1 Accompanying/underlying diseases in the NH
patients.
970 G. Karakaya et al.codeine, 173 with benzydamine, 162 with aspirin, 159 with
rofecoxib, and 26 with nabumetone.
Among the 278 patients that reported having adverse
reactions to paracetamol, 91 were challenged with para-
cetamol due to an unreliable history, and only 26 tested
positive (28.6%); however, 568 patients reported having
adverse reactions to aspirin, 61 were challenged with
aspirin due to an unreliable history, and 90% tested positive
(Table 2). The number of challenges shown in Table 2 may
seem low, but those drugs are COX-1 inhibitors and a history
of 2 episodes with the same drug or 2 episodes with 2
different drugs is sufficient for a diagnosis of NH.
Two patients had severe respiratory reactions after
aspirin provocation and were admitted to the intensive care
unit for follow-up; both were discharged the following day.
None of the patients in the study had local or general
anesthesia-related allergy as we reported before.17
Factors associated with asthma
The 724 patients without asthma were compared to the 413
patients with asthma. Table 3 shows the factors that were
associated with asthma in the NH patients. Female gender,
accompanying rhinitis/rhinosinusitis, nasal polyposis, his-
tory of polyp surgery, NSAID-induced rhinitis/asthma or
blended reaction, immediate reaction (<1 h after intake),
food allergy, and family history of asthma were associated
with asthma. History of smoking, the presence of chronicTable 2 Self-reported NSAID and paracetamol adverse reaction
Reported as safe
NSAIDs Total n Challenged n Positive
challenge n
ASA 75 10 1 (10)
Paracetamol 401 62 0
Metamizol 57 0 e
Naproxen 56 1 0
Flurbiprofen 7 0 eurticaria, NSAID-induced urticaria/angioedema or anaphy-
laxis, NSAID reactions 1e6 h after intake, antibiotic allergy,
and family history of drug and NSAID allergy were associ-
ated with the non-asthmatic NH phenotype.
Among the 413 NH patients with asthma, 109 (26.4%) had
NSAID-induced urticaria/angioedema-type reactions and
were categorized as pseudo Samter’s syndrome, and 304
(73.6%) had NSAID-induced anaphylaxis, rhinitis/asthma, or
blended reactions, and were categorized as Samter’s syn-
drome. Table 4 shows a comparison between these 2 sub-
groups. Interestingly, more patients with pseudo Samter’s
syndrome had a positive skin prick test, metal allergy,
antibiotic allergy, and chronic urticaria, were female, and
presented at a younger age.
Discussion
In the present study NH patients were grouped based on
accompanying chronic urticaria, asthma, and rhinitis/rhi-
nosinusitis, and differences between the groups were
identified. This study also analyzed the factors associated
with asthma in NH patients and a new classification scheme
for Samter’s syndrome was proposed. It is known that a
particular NSAID can induce different types of reactions in
different organ systems in the same and in different in-
dividuals.16 Some patients may develop a respiratory re-
action to an NSAID first, and then develop asthma and/or
rhinitis, as well as chronic urticaria. An asthmatic NH pa-
tient can exclusively experience urticaria/angioedema in
reaction to NSAIDs, as was observed in the present study;
among 413 NH patients with asthma, 109 (26%) had exclu-
sively urticaria/angioedema-type reactions to NSAIDs
(pseudo Samter’s syndrome). The clinical course and
prognosis in such patients is unknown, and it remains un-
clear if they go into remission or develop rhinitis/asthma-
type reactions later during the course of NH. In the pre-
sent study, patients with pseudo Samter’s syndrome more
frequently have accompanying chronic urticaria compared
to patients with Samter’s syndrome (30.3% versus 11.2%). It
was reported that when aspirin-tolerant asthmatics were
compared to those that were aspirin-intolerant (experi-
encing cough or dyspnea after taking NSAIDs), the rate of
aspirin-induced urticaria, atopic dermatitis, and rhinosi-
nusitis was higher in the aspirin-intolerant group.18
Celik et al. studied 190 NH patients in Turkey and re-
ported that asthmatic and urticarial reactions were more
common in the patients with asthma and chronic urticaria,
respectively.19 In the present study the prevalences of
chronic urticaria, asthma, and rhinitis were high; whens and oral provocation test results.
Self-reported adverse reaction
(%)
Total n Challenged n Positive
challenge n (%)
568 61 55 (90)
278 91 26 (28.6)
480 7 5 (71.4)
302 6 5 (83.3)
89 5 4 (80)
Table 3 Comparison of asthmatic and non-asthmatic NH patients to identify factors associated with asthma.
n (%) Total 1137
(100)
Asthmatic
413 (100)
Non-asthmatic
724 (100)
pa Or (95% CI)a
Female % 72.6 76.3 70.6 0.035 1.35 (1.02-1.78)
History of smoking 362 (31.8) 107 (25.9) 255 (35.2) 0.006 0.67 (0.51e0.89)
Chronic urticaria 241 (21.2) 67 (16.2) 174 (24) 0.002 0.60 (0.44e0.83)
Rhinitis/rhinosinusitis 475 (41.8) 316 (76.5) 159 (22) <0.001 12.06 (9e16.17)
Nasal polyposis 168 (14.8) 140 (33.9) 28 (3.9) <0.001 13.52 (8.74e20.9)
Polyp surgery 124 (10.9) 102 (24.7) 22 (3) <0.001 10.94 (6.73e17.77)
NSAID-induced urticaria/angioedema 631 (55.5) 108 (26.2) 523 (72.3) <0.001 0.13 (0.10e0.17)
NSAID-induced rhinitis/asthma 229 (20.2) 191 (46.2) 38 (5.3) <0.001 15.28 (10.45e22.36)
NSAID-induced blended reaction 148 (13) 80 (19.4) 68 (9.4) <0.001 2.43 (1.70e3.45)
NSAID-induced anaphylaxis 128 (11.3) 34 (8.2) 94 (13) 0.014 0.59 (0.39e0.9)
Immediate reaction to NSAIDs (<1 h) 789 (72.2) 314 (78.9) 475 (68.3) <0.001 1.76 (1.31e2.35)
Reaction in 1e6 h 276 (25.3) 82 (20.6) 194 (27.9) 0.007 0.67 (0.50e0.89)
Metal allergy 166 (14.6) 60 (14.5) 106 (14.6) 0.818 0.96 (0.67e1.36)
Antibiotic allergy 198 (17.4) 59 (14.3) 139 (19.2) 0.018 0.67 (0.48e0.93)
Food allergy 141 (12.4) 64 (15.5) 77 (10.6) 0.028 1.49 (1.04e2.14)
Family history of drug allergy 66 (5.8) 9 (2.2) 57 (7.9) <0.001 0.25 (0.12e0.52)
Family history of NH 90 (7.9) 22 (5.3) 68 (9.4) 0.010 0.52 (0.31e0.85)
Family history of chronic urticaria 47 (4.1) 12 (2.9) 35 (4.8) 0.153 0.61 (0.31e1.2)
Family history of asthma 291 (25.6) 164 (39.7) 127 (17.5) <0.001 3.1 (2.35e4.08)
Skin prick testb 211 (30) 93 (31.1) 118 (29.2) 0.437 1.14 (0.82e1.59)
The p values <0.05 are indicated in bold.
a p values and ORs were adjusted for age and gender for logistic regression analysis.
b Skin prick test was performed in 299 NH patients with asthma and in 404 NH patients without asthma.
Table 4 Comparison of the characteristics in the patients with Samter’s and pseudo Samter’s syndrome.
Pseudo Samter’s
syndrome n Z 109
Samter’s syndrome/
AERD n Z 304
p
Male/female % 15.6/84.4 26.6/73.4 0.020
Presence of rhinitis/rhinosinusitis 68 (62.4) 248 (81.6) <0.001
Presence of nasal polyps 10 (9.2) 130 (42.8) <0.001
Presence of chronic urticaria 33 (30.3) 34 (11.2) <0.001
Disease ordera n (%)
-First asthma then NH 55 (66.3) 184 (78.3) 0.029
Age at registration in database (years) 39.1  12 41.9  12 0.041
Age at onset of symptoms of rhinitis (years) 28.6  10.3 29  12.2 0.804
Age at onset of symptoms of asthma (years) 31.8  12.2 32.6  12.5 0.562
Age at nasal polyps diagnosis (years) 32.7  9.6 33.6  11.4 0.817
Age at onset of NH symptoms (years) 33.6  12 36.1  12.6 0.075
Oral steroid-dependent asthmab 3 (4.8) 12 (6.2) 0.694
Immediate reaction to NSAIDs (<1 h)c 71 (67.6) 243 (82.9) 0.001
Antibiotic allergy 28 (25.7) 31 (10.2) <0.001
Metal allergy 26 (23.9) 34 (11.2) 0.001
Food allergy 22 (20.2) 42 (13.8) 0.115
Family history of rhinitis 13 (11.9) 31 (10.2) 0.616
Family history of asthma 45 (41.3) 119 (39.1) 0.695
Family history of NH 8 (7.3) 14 (4.6) 0.27
Positive skin prick testd 29 (40.8) 64 (28.1) 0.042
History of polypectomy/endoscopic sinus surgery 8 (7.3) 94 (30.9) <0.001
The p values <0.05 are indicated in bold.
a Patients in which asthma and NH developed simultaneously were not included (n Z 95).
b Steroid dependence was based on patient files, and data are available for 256 (62%) patients.
c Time to reaction after NSAID intake was recorded in 398 patients and the percentages are given based on recorded cases.
d Skin prick testing was performed in 71 (65%) of the patients with pseudo Samter’s syndrome and in 228 (75%) of the patients with
Samter’s syndrome.
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972 G. Karakaya et al.compared to patients without an underlying disease (the
NH-N group) the most common (but not exclusive) reaction
pattern in the asthmatic patients was rhinitis/asthma, and
food and metal allergies were more common in the patients
with underlying chronic urticaria. Patients with 2 under-
lying diseases (the NH-O group) were different in most re-
spects. It is possible that NH patients can move from one
characteristic reaction group to another, and can even
achieve remission.6,20,21 Underlying/accompanying chronic
urticaria/asthma/rhinitis defines the reaction pattern to
NSAIDs, and NH can even become less severe when under-
lying/accompanying diseases go into remission.
The diagnosis of NH is based on a reported history of
adverse reactions to aspirin and/or other NSAIDs.1 Provo-
cation testing is required to confirm or exclude hypersen-
sitivity in cases with an unreliable history.15,22 A finding of
note in the present study is that 91 oral challenges with
paracetamol were performed in patients with an unreliable
history history and only 28.6% were positive. Paracetamol is
present as an ingredient in many NSAID medications, which
may have contributed to the high rate of false-reported
adverse reactions to paracetamol in the present study.
Additionally, because of anxiety, a group of patients may
have reported that paracetamol was nonsafe. Currently, we
are conducting a prospective study to evaluate the level of
anxiety in patients with drug hypersensitivity reactions.
Some patients initially have a rhinitis/asthma-type re-
action to NSAIDs, and then develop asthma during the
following years.22 Risk factors for the development of
asthma are not well known. We previously reported that
nasal polyposis, rhinosinusitis, and NH in childhood are
associated with the subsequent development of asthma in
patients with NH, and when compared to asthmatic pa-
tients analgesic-intolerant asthmatic patients moreFigure 2 Classification scheme for Samtecommonly had dermographism, chronic urticaria, antibi-
otic, metal, and food allergies, high serum total IgE level,
and higher cumulative analgesic consumption.23e25 In
addition to nasal polyposis and rhinitis/rhinosinusitis in the
present study population, we observed that female gender,
history of polyp surgery, NSAID-induced rhinitis/asthma or a
blended reaction pattern, reaction <1 h after NSAID intake,
history of food allergy, and family history of asthma were
the factors associated with asthma. A recently published
study from Korea reported that 5.8% of asthma patients
have NH, and when compared to aspirin-tolerant patients
they observed that the aspirin-induced urticaria rate was
significantly higher in the patients that were aspirin intol-
erant (49.2% and 2.7%, respectively p < 0.001).18
There are many published classification schemes for NH
reactions.1,2,15,16,26,27 As such, we propose a classification
based on clinical characteristics and reaction patterns
observed in the present study’s Turkish patients.
Asthmatic attacks and/or nasal symptoms caused by
NSAIDs is defined as AERD, which is also referred to as
aspirin triad, asthma triad, Widal syndrome, Samter’s syn-
drome, aspirin-induced asthma, aspirin-intolerant asthma,
and aspirin-sensitive rhinosinusitis/asthma syndrome.1,9
We previously reported that AERD patients are heteroge-
neous and must be classified, and a classification scheme
(Kalyoncu classification) proposed.27,28 In the present
study, we proposed a new classification scheme for Samt-
er’s syndrome (Fig. 2). To the best of our knowledge this is
the first use of the term pseudo Samter’s syndrome; how-
ever, 26.4% of the present study’s NH patients with asthma
had NSAID-induced urticaria/angioedema and were classi-
fied as pseudo Samter’s syndrome, NH patients with asthma
and NSAID-induced rhinitis/asthma-type reactions were
classified as Samter’s syndrome, as the sine qua non for ther’s syndrome (Kalyoncu classification).
NSAID hypersensitivity and asthma 973diagnosis of Samter’s syndrome is the presence of asthma
and COX enzyme-mediated aspirin-induced exacerbation of
asthma. In addition, there might be incomplete forms of
the disease; in such cases rhinitis/rhinosinusitis/nasal pol-
yposis can accompany NH without asthma. Although clini-
cians are aware of the incomplete forms of Samter’s
syndrome, the clinical course is not well known. Incomplete
forms of Samter’s syndrome were classified separately in
the present study. Prospective cohort studies are required
to further evaluate incomplete Samter’s phenotypes.
Although the guideline-based and patient reported
asthma control level was similar between Europe and
Turkey, the oral steroid-dependent asthma rate in the
present study’s patients with Samter’s syndrome was much
lower than reported earlier.9,29,30 One comparable study
published in 2000, reported that the steroid-dependent
asthma rate in patients with AERD was 51.4%, and that
80% of the study population used inhaler corticosteroids for
chronic asthma.9 All the patients with Samter’s syndrome in
the present study were using inhaler steroids. Although, it
is not known why the oral steroid-dependent asthma rate in
the present study was so much lower, genotype differences
could be a reason.
The level of biomarkers that could have classified the
present study’s patients more accurately was not studied,
which is a limitation of the study. Previous classification
studies did not examine biomarkers, and classification
studies have primarily been based on clinical characteris-
tics.1,9,15,16 The comparison of the severity of asthma be-
tween groups, and the natural course of the phenotypes
could not be analyzed because of the retrospective nature
of the study.
In conclusion, chronic urticaria, rhinitis, and asthma
were common among the present study’s NH patients; in
some cases they preceded NH and in others they developed
during the course of NH, the natural course of which re-
mains to be fully known. NSAID response patterns in NH
patients may help differentiate groups of patients. The
present study identified factors associated with asthma in
NH patients and observed that there seems to be different
phenotypes of Samter’s syndrome, for which a new classi-
fication scheme was proposed. Additional research is
required to more clearly delineate the behavior and natural
course of pseudo Samter’s syndrome, as well as incomplete
forms of the disease.Conflict of interest
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